Malaria Consortium's seasonal malaria chemoprevention (SMC) programme distributes preventative antimalarial drugs to young children during times of peak malaria transmission.
Malaria kills around 600,000 people each year, the majority of whom are children under 5. Malaria Consortium reports that malaria, a preventable and treatable disease, threatens 3.2 billion people globally.
Malaria Consortium’s mission is “to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat targeted diseases and promote child and maternal health.”
Malaria Consortium fights malaria and other diseases through a variety of strategies and programmes. Its seasonal malaria chemoprevention (SMC) programme distributes preventative antimalarial drugs to young children during times of peak malaria transmission.
Through its SMC programme, Malaria Consortium:
See more on the programme webpage, in GiveWell’s research, or on the EA Forum.
This fundraiser was set up as part of the EA Forum Donation Election event, but it’s a normal fundraiser: donations to this fundraiser will be designated for the Malaria Consortium, not for the Donation Election Fund or anything else.
Please also note that donating to this fundraiser does not count as a vote for the Malaria Consortium in the Election (see more about how the Election works here.)
The Forum Team (or the Online Team at the Centre for Effective Altruism) runs the EA Forum, the EA Newsletter, and the EA Forum Digest, and works on some other projects. Find them on the EA Forum.
Seasonal Malaria Chemoprevention
The Seasonal Malaria Chemoprevention program protects children from malaria by distributing preventative medication at times of high transmission.